Infant leukemia, topoisomerase II inhibitors, and the MLL gene.
Ross
J A
JA
Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis.
Potter
J D
JD
Robison
L L
LL
D000208:Acute Disease; D002869:Chromosome Aberrations; D002880:Chromosomes, Human, Pair 11; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics; D007951:Leukemia, Myeloid / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D059005:Topoisomerase II Inhibitors
D059005:Topoisomerase II Inhibitors